Katagiri H, et al. - The safety and effectiveness of rapid-acting intramuscular (IM) olanzapine were evaluated in the treatment of acute agitation associated with schizophrenia in real-world clinical settings in Japan. In the treatment of schizophrenia patients with acute agitation, IM olanzapine was found to be safe and had a favorable effectiveness profile.